Lytix Biopharma and ABG Sundal Collier signs collaboration agreement
Unni Hjelmaas (CEO of Lytix Biopharma AS) and Peter Straume (partner at ABG Sundal Collier ASA, Norway) signed a collaboration agreement on Thursday October 18th 2012.
The agreement states that ABGSC will assist the company as financial advisor and strategic partner. ABGSC shall provide services in structuring, organization and planning of future financing of Lytix Biopharma.
Lytix Biopharma's former financial partner, Sparebank1 Nord-Norge Markets, has agreed to join as co-manager.